• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    35 Stocks Moving In Monday's Mid-Day Session

    4/4/22 12:12:22 PM ET
    $AERC
    $ARRY
    $ATER
    $BILI
    Environmental Services
    Utilities
    Miscellaneous manufacturing industries
    Consumer Discretionary
    Get the next $AERC alert in real time by email

    Gainers

    • Aterian, Inc. (NASDAQ:ATER) shares jumped 43.5% to $3.3457. Aterian said Cynthia Williams has joined the Company's Board of Directors.
    • Jumia Technologies AG (NASDAQ:JMIA) gained 29.5% to $12.28 after the company announced it would make its last mile logistics capabilities available to UPS.
    • Twitter, Inc. (NYSE:TWTR) shares climbed 25.7% to $49.42 after Tesla CEO Elon Musk disclosed a 9.2% passive stake in the social media company.
    • LianBio (NASDAQ:LIAN) jumped 23.4% to $4.6050.
    • Clovis Oncology, Inc. (NASDAQ:CLVS) jumped 21% to $3.0250.
    • SPI Energy Co., Ltd. (NASDAQ:SPI) gained 19% to $3.3792 after reporting record revenue of $162 million for 2021.
    • Dingdong (Cayman) Limited (NYSE:DDL) jumped 18.4% to $4.3231.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) gained 18% to $14.60.
    • Gracell Biotechnologies Inc. (NASDAQ:GRCL) rose 17.8% to $2.64 after BTIG initiated coverage on the stock with a Buy rating and a $18 price target.
    • Biophytis SA (NASDAQ:BPTS) surged 16.5% to $2.6106.
    • Borr Drilling Limited (NYSE:BORR) gained 16.4% to $4.72.
    • Array Technologies, Inc. (NASDAQ:ARRY) surged 16.4% to $12.74 after the company announced it will supply advanced tracker technology for "the largest solar + storage project in the US."
    • Pinduoduo Inc. (NASDAQ:PDD) gained 16.4% to $49.79 following a potential rule change which would allow Chinese companies to share sensitive data with US regulators, thus lowering risk of delisting.
    • Nuvve Holding Corp. (NASDAQ:NVVE) surged 15.8% to $8.12. Nuvve Holding recently reported Q4 financial results.
    • Inozyme Pharma, Inc. (NASDAQ:INZY) gained 15.5% to $4.3559 as the company announced preliminary biomarker, safety, and pharmacokinetic (PK) data from the first three patients treated in the Phase 1 portion of its Phase 1/2 trial of INZ-701 in ENPP1 Deficiency.
    • Futu Holdings Limited (NASDAQ:FUTU) jumped 15.4% to $39.95.
    • Full Truck Alliance Co. Ltd. (NYSE:YMM) surged 15.3% to $8.27.
    • Perion Network Ltd. (NASDAQ:PERI) gained 15.3% to $26.39 after the company reported better-than-expected Q1 financial results.
    • iQIYI, Inc. (NASDAQ:IQ) gained 14.7% to $5.49.
    • RCM Technologies, Inc. (NASDAQ:RCMT) surged 14.3% to $12.51.
    • Borqs Technologies, Inc. (NASDAQ:BRQS) rose 14.1% to $0.2395. TDR Capital reported a new stake of 9.9% in Borqs Technologies.
    • The RealReal, Inc. (NASDAQ:REAL) gained 13.5% to $8.19.
    • Bilibili Inc. (NASDAQ:BILI) rose 13.4% to $31.33 after surging 8% on Friday.
    • Ollie's Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) gained 12.8% to $48.36 after Wells Fargo upgraded the stock from Equal-Weight to Overweight and announced a $65 price target.
    • ironSource Ltd. (NYSE:IS) jumped 12.3% to $5.24.
    • TMC the metals company Inc. (NASDAQ:TMC) rose 12.2% to $2.75.
    • Context Therapeutics Inc. (NASDAQ:CNTX) shares rose 7.5% to $2.58 after jumping over 10% on Friday. Context
    • Therapeutics recently posted FY21 net loss of $10.5 million.
    • Infobird Co., Ltd (NASDAQ:IFBD) shares rose 7.1% to $0.7499. Infobird recently announced receipt of delinquency notification letter from Nasdaq.

     

    Losers

    • Curis, Inc. (NASDAQ:CRIS) shares tumbled 38.3% to $1.50. The FDA has placed a partial clinical hold on Curis Inc's TakeAim Leukemia Phase 1/2a study in relapsed or refractory (R/R) acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS).
    • GWG Holdings, Inc. (NASDAQ:GWGH) dropped 20.5% to $4.24.
    • Snow Lake Resources Ltd. (NASDAQ:LITM) fell 20.1% to $8.02.
    • Forge Global Holdings, Inc. (NYSE:FRGE) dipped 16.6% to $24.75.
    • Rail Vision Ltd. (NASDAQ:RVSN) declined 15.5% to $2.2997 following Thursday's IPO.
    • Longeveron Inc. (NASDAQ:LGVN) dropped 15.4% to $13.21. A leading medical journal published study of Longeveron's Phase 1 trial results for Alzheimer's disease.
    • Iveda Solutions, Inc. (NASDAQ:IVDA) fell 15% to $3.2050. Iveda reported pricing of $8.0 million public offering, uplisting to Nasdaq and reverse stock split.
    • Insignia Systems, Inc. (NASDAQ:ISIG) dropped 14.4% to $10.85.
    • AeroClean Technologies, Inc. (NASDAQ:AERC) fell 13.8% to $3.9450. AeroClean Technologies recently posted a Q4 loss of $0.13 per share.
    • Vertex Energy, Inc. (NASDAQ:VTNR) dropped 13.3% to $8.59.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) fell 13% to $55.03 amid Tesla CEO Elon Musk purchasing a 9.2% stake in competitor Twitter.
    • Expion360 Inc. (NASDAQ:XPON) dipped 12.7% to $6.92. This new issue opened for trade on Friday of last week.
    • NextDecade Corporation (NASDAQ:NEXT) declined 10.2% to $6.23. Credit Suisse recently downgraded NextDecade from Outperform to Neutral and raised the price target from $3 to $7.5.
    • Weidai Ltd. (NYSE:WEI) fell 9.4% to $1.2950 after jumping 29% on Friday.
    • Sharps Compliance Corp. (NASDAQ:SMED) dropped 9.4% to $5.20. Sharps Compliance named Pat Mulloy as CEO.
    • Matson, Inc. (NASDAQ:MATX) dipped 7.2% to $107.26.
    • Hudson Capital Inc. (NASDAQ:HUSN) shares fell 7.2% to $2.4399. Hudson Capital shares jumped 36% on Friday after the company announced it sold its wholly-owned subsidiary, Hong Kong Internet Financial Services, to private investors.
    Get the next $AERC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AERC
    $ARRY
    $ATER
    $BILI

    CompanyDatePrice TargetRatingAnalyst
    NextDecade Corporation
    $NEXT
    2/6/2026$7.00Overweight
    CapitalOne
    Jumia Technologies AG
    $JMIA
    2/6/2026$18.00Overweight
    Cantor Fitzgerald
    Futu Holdings Limited
    $FUTU
    2/2/2026$213.39Neutral → Buy
    Goldman
    Array Technologies Inc.
    $ARRY
    1/28/2026$11.00Outperform → Neutral
    Robert W. Baird
    Full Truck Alliance Co. Ltd.
    $YMM
    1/12/2026Neutral → Underweight
    Analyst
    Array Technologies Inc.
    $ARRY
    1/9/2026$12.00Hold → Buy
    TD Cowen
    Ollie's Bargain Outlet Holdings Inc.
    $OLLI
    12/22/2025$135.00Hold → Buy
    Loop Capital
    Jumia Technologies AG
    $JMIA
    12/16/2025$18.00Buy
    Craig Hallum
    More analyst ratings

    $AERC
    $ARRY
    $ATER
    $BILI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-13) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 12/21/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    12/22/22 4:37:40 AM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-11) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 06/10/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    6/13/22 2:20:18 PM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERC
    $ARRY
    $ATER
    $BILI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CapitalOne initiated coverage on NextDecade with a new price target

    CapitalOne initiated coverage of NextDecade with a rating of Overweight and set a new price target of $7.00

    2/6/26 8:35:07 AM ET
    $NEXT
    Oil & Gas Production
    Utilities

    Cantor Fitzgerald initiated coverage on Jumia with a new price target

    Cantor Fitzgerald initiated coverage of Jumia with a rating of Overweight and set a new price target of $18.00

    2/6/26 8:11:07 AM ET
    $JMIA
    Catalog/Specialty Distribution
    Consumer Discretionary

    Futu Holdings upgraded by Goldman with a new price target

    Goldman upgraded Futu Holdings from Neutral to Buy and set a new price target of $213.39

    2/2/26 6:47:07 AM ET
    $FUTU
    Investment Bankers/Brokers/Service
    Finance

    $AERC
    $ARRY
    $ATER
    $BILI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Karkar Andrei exercised 63,682 shares at a strike of $0.52, increasing direct ownership by 19% to 394,009 units (SEC Form 4)

    4 - TMC the metals Co Inc. (0001798562) (Issuer)

    2/5/26 7:47:55 PM ET
    $TMC
    Metal Mining
    Basic Materials

    Executive Chairman Swygert John W converted options into 2,091 shares and covered exercise/tax liability with 965 shares, increasing direct ownership by 2% to 49,326 units (SEC Form 4)

    4 - Ollie's Bargain Outlet Holdings, Inc. (0001639300) (Issuer)

    2/5/26 5:05:04 PM ET
    $OLLI
    Department/Specialty Retail Stores
    Consumer Discretionary

    President and CEO Van Der Valk Eric converted options into 3,717 shares and covered exercise/tax liability with 1,662 shares, increasing direct ownership by 26% to 9,816 units (SEC Form 4)

    4 - Ollie's Bargain Outlet Holdings, Inc. (0001639300) (Issuer)

    2/5/26 5:01:50 PM ET
    $OLLI
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AERC
    $ARRY
    $ATER
    $BILI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hanwha Aerospace Co., Ltd. bought $9,399,378 worth of shares (1,651,971 units at $5.69) (SEC Form 4)

    4 - NextDecade Corp (0001612720) (Issuer)

    12/15/25 7:12:58 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    Large owner Hanwha Aerospace Co., Ltd. bought $5,742,414 worth of shares (932,598 units at $6.16) (SEC Form 4)

    4 - NextDecade Corp (0001612720) (Issuer)

    12/10/25 8:15:10 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    Large owner Hanwha Aerospace Co., Ltd. bought $3,910,470 worth of shares (636,963 units at $6.14) (SEC Form 4)

    4 - NextDecade Corp (0001612720) (Issuer)

    12/5/25 6:29:01 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    $AERC
    $ARRY
    $ATER
    $BILI
    SEC Filings

    View All

    SEC Form 6-K filed by Rail Vision Ltd.

    6-K - Rail Vision Ltd. (0001743905) (Filer)

    2/6/26 4:00:21 PM ET
    $RVSN
    Railroads
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Array Technologies Inc.

    SCHEDULE 13G/A - Array Technologies, Inc. (0001820721) (Subject)

    2/6/26 12:08:56 PM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    SEC Form 6-K filed by Bilibili Inc.

    6-K - Bilibili Inc. (0001723690) (Filer)

    2/6/26 6:01:30 AM ET
    $BILI
    EDP Services
    Technology

    $AERC
    $ARRY
    $ATER
    $BILI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Context Therapeutics to Participate in Upcoming Investor Conferences

    PHILADELPHIA, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. ("Context" or the "Company") (NASDAQ:CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced its participation in several upcoming investor conferences. Upcoming Investor Conferences Guggenheim Emerging Outlook: Biotech Summit 2026, February 11-12, 2026, New York, NYFireside Chat: Wednesday, February 11th at 8:30 AM ET1x1 Meetings on February 11th TD Cowen 46th Annual Health Care Conference, March 2-4, 2026, Boston, MAPresentation: Tuesday, March 3rd at 10:30 AM ET*1x1 Meetings on March 3rd Citizens Life Sciences Conference, March 10-11,

    2/9/26 7:30:00 AM ET
    $CNTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rail Vision Advances Strategic Collaboration with Israel Railways Cargo Division

    With its MainLine product already installed on Israel Railways' locomotives, this collaboration aims to expand Rail Vision's product offering by deploying its ShuntingYard product within Israel Railways' cargo division Ra'anana, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (NASDAQ:RVSN) ("Rail Vision" or the "Company"), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, announced today its advancement to the next phase of its collaboration with Israel Railways. As previously announced, Israel Railways purchased and installed Rail Vision's MainLine systems on its locomotives and this advancement marks the

    2/6/26 8:32:00 AM ET
    $RVSN
    Railroads
    Industrials

    Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program

    The Mikaela Naylon Give Kids a Chance Act reauthorizes the Pediatric Priority Review Voucher (PPRV) Program and extends eligibility for medicines achieving U.S. FDA approval before September 2029The Pediatric Priority Review Voucher program encourages the development of treatments for rare pediatric diseasesU.S. FDA has awarded Longeveron's laromestrocel Hypoplastic Left Heart Syndrome (HLHS) program Rare Pediatric Disease designation, Orphan Drug designation, and Fast Track designationWith the extension of the PPRV Program, Longeveron may be granted a Priority Review Voucher if laromestrocel's Biological License Application (BLA) is approved by the FDA before September 2029 MIAMI, Feb. 05

    2/5/26 9:15:00 AM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERC
    $ARRY
    $ATER
    $BILI
    Leadership Updates

    Live Leadership Updates

    View All

    Expion360 Appoints Joseph Hammer as Chief Executive Officer and Chairman of the Board

    Veteran Financial Executive and Board Director to Lead Strategic Direction and Next Phase of Growth  REDMOND, Ore., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Expion360 Inc. (NASDAQ:XPON) ("Expion360" or the "Company"), an industry leader in lithium-ion battery power storage, today announced the appointment of Joseph Hammer as Chief Executive Officer and Chairman of the Board of Directors, effective October 16, 2025, succeeding Brian Schaffner, Chief Executive Officer, and Paul Shoun, President and Chairman of the Board, both of whom have stepped down from their respective roles at the Company. Mr. Schaffner will serve as a member of the Board of Directors. Joseph Hammer brings over 20 years' exp

    10/28/25 8:31:00 AM ET
    $XPON
    Industrial Machinery/Components
    Miscellaneous

    Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer

    Karen Smith, MD, PhD, MBA, LLM, joins with over 25 years of global pharma and biotech experience, having contributed to more than 20 regulatory approvals Dr Smith's appointment will accelerate Step Pharma's ‘pipeline in a product' strategy, leveraging her clinical and regulatory expertise to advance dencatistat, afirst-in-class CTPS1 inhibitor across multiple cancer and blood disorder indicationsAppointment follows Step Pharma's recently announced €38 million Series C financing Saint-Genis-Pouilly, France, 28 October 2025 – Step Pharma ("the Company"), the global leader in CTPS1 inhibition for targeted cancer treatment, today announces the appointment of Karen L. Smith, MD, PhD, MBA, LLM a

    10/28/25 8:00:00 AM ET
    $CNTX
    $SKYE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NextDecade Announces Chief Financial Officer Transition

    NextDecade Corporation (NextDecade or the Company) (NASDAQ:NEXT) announced today that Brent Wahl, Chief Financial Officer, has resigned from the Company effective October 20, 2025, and the Company has appointed Mike Mott, Senior Vice President Enterprise Transformation, as Interim Chief Financial Officer effective October 20, 2025. Mr. Wahl is leaving NextDecade to join a digital infrastructure company, and he has agreed to serve in a consultant capacity through December 31, 2025, to facilitate a seamless transition. The Company will initiate a comprehensive search process to find a permanent successor. "I want to thank Brent for the significant impact he has made at NextDecade," said M

    10/8/25 8:00:00 AM ET
    $NEXT
    Oil & Gas Production
    Utilities

    $AERC
    $ARRY
    $ATER
    $BILI
    Financials

    Live finance-specific insights

    View All

    ARRAY Technologies Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

    ALBUQUERQUE, N.M., Feb. 04, 2026 (GLOBE NEWSWIRE) -- ARRAY Technologies, Inc. (the "Company" or "ARRAY") (NASDAQ:ARRY), a leading global provider of solar tracking technology products, software, services and foundation solutions, today announced that the Company will release its fourth quarter and full year 2025 results after the market closes on Wednesday, February 25, 2026, to be followed by a conference call at 5:00 p.m. (Eastern Time) that same day. The conference call can be accessed live over the phone by dialing (877)-869-3847 (domestic) or (201)-689-8261 (international), or via webcast of the live conference call by logging onto the Investor Relations section of the Company's webs

    2/4/26 4:05:00 PM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Borr Drilling Limited - Invitation to Webcast and Conference Call for Q4 2025 Results

    HAMILTON, Bermuda, Jan. 30, 2026 /PRNewswire/ -- Borr Drilling Limited (NYSE and Euronext Growth Oslo: BORR) (the "Company") plans to release its financial results for the fourth quarter of 2025 after the close of the New York Stock Exchange on Wednesday, February 18, 2026. A conference call and webcast are scheduled for 09:00 New York time (15:00 CET) on Thursday, February 19, 2026. The earnings report, webcast and accompanying presentation will be available on the Investor Relations section of the Company's website, www.borrdrilling.com. In order to listen to the live presentation, participants may do one of the following: a)    Webcast To access the webcast, please go to the following l

    1/30/26 10:09:00 AM ET
    $BORR
    Oil & Gas Production
    Energy

    NOBLE CORPORATION PLC COMPLETES SALE OF FIVE JACKUPS TO BORR DRILLING

    HOUSTON, Jan. 28, 2026 /PRNewswire/ -- Noble Corporation plc (NYSE:NE, ", Noble", , or the ", Company", )) today announced that it has completed the sale of five jackup rigs to Borr Drilling Limited (NYSE:BORR, ", Borr", )) for $360 million. The Company generated approximately $210 million in cash plus $150 million in seller notes from the sale of the Noble Tom Prosser, Noble Mick O'Brien, Noble Regina Allen, Noble Resilient and Noble Resolute. Noble intends to operate two rigs – Noble Mick O'Brien and Noble Resolute – under a bareboat charter agreement with Borr until December 2026, as well as the Noble Resilient through the remainder of its current contract term (including exercise of any

    1/28/26 5:08:00 PM ET
    $BORR
    $NE
    Oil & Gas Production
    Energy

    $AERC
    $ARRY
    $ATER
    $BILI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Inozyme Pharma Inc.

    SC 13G - Inozyme Pharma, Inc. (0001693011) (Subject)

    12/9/24 4:14:49 PM ET
    $INZY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by iQIYI Inc.

    SC 13D/A - iQIYI, Inc. (0001722608) (Subject)

    12/4/24 8:11:53 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Full Truck Alliance Co. Ltd.

    SC 13G/A - Full Truck Alliance Co. Ltd. (0001838413) (Subject)

    12/3/24 4:30:33 PM ET
    $YMM
    Computer Software: Prepackaged Software
    Technology